Connect with us

People & Lifestyle

The European Union grants DEK Vaccines LTD EUR 5 million to support vaccine manufacturing in Ghana

Published

on

The European Union (EU) and DEK Vaccines Limited have signed a grant deal worth €5 million to help Ghana’s ambition to manufacture vaccines.

The funding provided by the European Investment Bank, will act as seed capital, among other things, for the establishment of the DEK Vaccines Limited vaccine production unit.

In a brief ground breaking ceremony held on Thursday 18th April, 2023 at Medie – Accra, the Managing director of DEK Vaccines Limited, Pharm. Dr. Kofi Nsiah – Poku gave a brief remarks and words of gratitude to the European Union for their support.

Advertisement

“We  wish to express our gratitude to the European Union who have generously granted DEK EUR 5 million through the European Investment Bank to support vaccine manufacturing in Ghana.

Read also:New Mosquito Species Found in Ghana- MOH warns

This ground-breaking event marks the largest single manufacturing factory of vaccines in Africa, and is a perfect example of the strong public support for the private sector,” he said.

Special guest of honor, H.E Nana Addo Dankwah Akuffo Addo also delivered a brief speech ensuring and supporting the development of the country.

Advertisement

Recognizing the critical importance of health infrastructure in promoting sustainable health security against infectious diseases across the globe and particularly in the African region, the Government of Ghana has prioritized vaccine manufacturing in Ghana as a key component of its healthcare strategy.

The DEK Vaccine manufacturing factory in Accra, Ghana, represents a significant project aimed at manufacturing 600 million doses of vaccines annually, including vaccines for Malaria, HPV, Pneumonia, Rotavirus, and Cholera, with the full value chain. Beginning with Fill and Finish, the project will eventually incorporate vaccine manufacturing and production, with a plan to construct a total of four Fill and Finish lines that can fill any type of vaccine.

Using the latest state-of-the-art technology, the Fill and Finish facility will have the capability to fill both mRNA and traditional vaccines. The development of DEK Vaccines Limited will carry both direct and indirect socio-economic benefits, as the adoption and maintenance of reliable health security infrastructure which will serve as the foundation for sustainable economic growth.

Read also: Ghana approves second malaria vaccine

Advertisement

DEK’s investment of USD 122.6 million will complete the first phase of the project, providing employment for over 250 full-time employees. This is a significant step towards securing the health of Ghanaians and Africans as a whole, through locally manufactured vaccines that meet global quality standards.

Speaking also at the ground breaking ceremony were Ambassador of delegation of European Union to Ghana, H.E Ambassador M. Irchad Razaaly, Chairman, Vaccine Manufacturing committee, Prof. Kwabena Frimpong Boateng, British High Commissioner to Ghana, Harriet Thompson and MP Regional Minister, Hon. Henry Quartey.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
You want to bet with the best odds on every football match? bestbets.com.gh shows you the highest odds for all important games.